| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Harrow, Inc.'s insiders have reduced their positions by a net 11,250 shares worth roughly $450K.
HROW sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.68M | $146.05M | - | |
| CEO | 3.00M | $90.48M | - | |
| CFO | 814.7K | $24.36M | - | |
| Dir | 1.0K | $31.1K | - | |
| Dir | 1.0K | $31.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2025 | Opaleye Management Inc.60 | 10% Owner | Sell | 15,000 | $26.13 | $391,904.00 | -10.7% | +28.4% | - | |
| Mar 18, 2025 | Opaleye Management Inc.60 | 10% Owner | Sell | 5,000 | $30.01 | $150,055.00 | -3.4% | +16.9% | +27.8% | |
| Mar 18, 2025 | Opaleye Management Inc.60 | 10% Owner | Sell | 5,000 | $29.64 | $148,200.00 | -3.3% | +16.9% | +27.8% | |
| Feb 28, 2025 | Opaleye Management Inc.60 | 10% Owner | Sell | 5,000 | $28.05 | $140,250.00 | -3.2% | -3.1% | +92.9% | |
| Jan 22, 2025 | Opaleye Management Inc.60 | 10% Owner | Sell | 20,000 | $35.59 | $711,814.00 | -11.4% | -33.7% | +31.2% | |
| Apr 25, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 20,000 | $9.97 | $199,400.00 | +0.5% | +138.7% | +155.5% | |
| Apr 24, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 20,000 | $10.23 | $204,640.10 | +0.5% | +138.4% | +144.1% | |
| Apr 19, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 29,400 | $10.56 | $310,390.50 | +0.8% | +135.3% | +122.4% | |
| Mar 28, 2024 | Opaleye Management Inc.60 | 10% Owner | Buy | 50,000 | $12.82 | $641,000.00 | +1.4% | +61.3% | +98.1% | |
| Mar 22, 2024 | Baum Mark L66 | Chief Executive Officer | Buy | 9,000 | $11.59 | $104,310.00 | +0.4% | +73.3% | +147.0% |